Portal de Periódicos da CAPES

Analysis of radiological findings in treated breast cancer patients who had mammography in the state of Tocantins in 2023

2024; Brazilian Society of Mastology; Linguagem: Inglês

10.29289/259453942024v34s1071

2594-5408

Cândida Verônica de Andrade Paz, Inês Duarte, Eduarda Martins dos Santos, Karoline Nunes Rodrigues Viana, Jascyone Barbosa da Silva, Rafael Pereira Camargo, Tássia Aimê Teixeira Nascimento, Fabiana Cândida Queiroz Santos Anjos,

Cancer Risks and Factors

Objective: This study aimed to evaluate the results obtained in mammography in 2023 in women above 30 years old who previously had breast cancer treatment in the state of Tocantins. Methodology: This is a quantitative and comparative study of mammography results in treated breast cancer patients. It reunited data from the Cancer Information System (SISCAN/DATASUS) using biological sex, time, and location of the exam as filters, evaluating new radiological findings. Results: In 2023, 229 mammographies were done in women above 30 years of age who previously had breast cancer. It was analyzed according to the Breast Imaging Reporting and Data System (BI-RADS). It was observed an expressive number of BI-RADS 2 with a prevalence of 86.89%, followed by 8.73% represented by BI-RADS 0 and 3.05% Bi-RADS 4. The categories BI-RADS 1, 3, and 5 presented the same percentage with only 0.43%. The age group with the highest number of radiological findings was between 60 and 64 years old, which constitutes 46 exams of the total studied; this number had 37 classified as Bi-RADS 2, 3 as BI-RADS 4, and 1 as BI-RADS 5. The last one was the only finding of the sample that is in this category, which represents 1.74% of the sample with suspect lesions. Conclusion: Screening the more considered risk population than usual is necessary in the face of the current prevalence of radiological findings. However, data analysis shows a bigger concern among women between 60 and 64 years old, as there was a recurrence of highly suspect findings only in this age group in 2023.